Michael F. Powell

3.1k total citations
64 papers, 2.5k citations indexed

About

Michael F. Powell is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Michael F. Powell has authored 64 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 15 papers in Molecular Biology and 14 papers in Pharmaceutical Science. Recurrent topics in Michael F. Powell's work include Chemical Reactions and Isotopes (10 papers), HIV Research and Treatment (9 papers) and Immunotherapy and Immune Responses (8 papers). Michael F. Powell is often cited by papers focused on Chemical Reactions and Isotopes (10 papers), HIV Research and Treatment (9 papers) and Immunotherapy and Immune Responses (8 papers). Michael F. Powell collaborates with scholars based in United States, Canada and Australia. Michael F. Powell's co-authors include Mark J. Newman, Thomas C. Bruice, Frederick R. Vogel, A. J. Kresge, F C Gaeta, Amy Lim, S M Colón, Jeffrey L. Cleland, Alessandro Sette and Charlotte R. Kensil and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Immunology and Analytical Chemistry.

In The Last Decade

Michael F. Powell

62 papers receiving 2.4k citations

Peers

Michael F. Powell

IMMUN

EPIDE

MICRO

Virander S. Chauhan India

Joshua Boger United States

Marco Marradi Spain

William Egan United States

Dermot Cox Ireland

G. Jung Germany

William E. Stewart United States

Ye Liu China

Kang Chen United States

Philippe M. Loiseau France

Virander S. Chauhan India

Michael F. Powell

2.6k ×2.5

925 ×1.1

IMMUN

1.0k ×2.4

403 ×1.0

EPIDE

412 ×1.6

MICRO

Citations per year, relative to Michael F. Powell Michael F. Powell (= 1×) peers Virander S. Chauhan

Countries citing papers authored by Michael F. Powell

Since Specialization

Citations

This map shows the geographic impact of Michael F. Powell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Powell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Powell more than expected).

Fields of papers citing papers by Michael F. Powell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael F. Powell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Powell. The network helps show where Michael F. Powell may publish in the future.

Co-authorship network of co-authors of Michael F. Powell

This figure shows the co-authorship network connecting the top 25 collaborators of Michael F. Powell. A scholar is included among the top collaborators of Michael F. Powell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael F. Powell. Michael F. Powell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bernaitis, Nijole, et al.. (2018). Simulated patient cases using DecisionSim™ improves student performance and satisfaction in pharmacotherapeutics education. Currents in Pharmacy Teaching and Learning. 10(6). 730–735. 22 indexed citations

Winter, Kathleen, et al.. (2016). Effectiveness of Prenatal Versus Postpartum Tetanus, Diphtheria, and Acellular Pertussis Vaccination in Preventing Infant Pertussis. Clinical Infectious Diseases. 64(1). 3–8. 126 indexed citations

Evans, Thomas G., M. Juliana McElrath, Thomas J. Matthews, et al.. (2001). QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans. Vaccine. 19(15-16). 2080–2091. 106 indexed citations

Cleland, Jeffrey L., Amy Lim, Ann L. Daugherty, et al.. (1998). Development of a single‐shot subunit vaccine for HIV‐1. 5. Programmable in vivo autoboost and long lasting neutralizing response. Journal of Pharmaceutical Sciences. 87(12). 1489–1495. 24 indexed citations

Özpolat, Bülent, Xiao‐Mei Rao, Michael F. Powell, & Lawrence B. Lachman. (1998). Immunoliposomes Containing Antibodies to Costimulatory Molecules as Adjuvants for HIV Subunit Vaccines. AIDS Research and Human Retroviruses. 14(5). 409–417. 8 indexed citations

Newman, Mark J., Benjamin Gardner, Charlotte R. Kensil, et al.. (1997). Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations. Vaccine. 15(9). 1001–1007. 53 indexed citations

Cleland, Jeffrey L., Lorena Barrón, Ann L. Daugherty, et al.. (1996). Development of a Single-Shot Subunit Vaccine for HIV-1. 3. Effect of Adjuvant and Immunization Schedule on the Duration of the Humoral Immune Response to Recombinant MN gp120. Journal of Pharmaceutical Sciences. 85(12). 1350–1357. 26 indexed citations

Cleland, Jeffrey L., Charlotte R. Kensil, Amy Lim, et al.. (1996). Isomerization and Formulation Stability of the Vaccine Adjuvant QS-21. Journal of Pharmaceutical Sciences. 85(1). 22–28. 73 indexed citations

Jacobsen, Neil E., et al.. (1996). Structure of the saponin adjuvant QS-21 and its base-catalyzed isomerization product by 1H and natural abundance 13C NMR spectroscopy. Carbohydrate Research. 280(1). 1–14. 96 indexed citations

10.

Cleland, Jeffrey L., Lorena Barrón, Phillip W. Berman, et al.. (1996). Development of a Single-Shot Subunit Vaccine for HIV-1. 2. Defining Optimal Autoboost Characteristics To Maximize the Humoral Immune Response. Journal of Pharmaceutical Sciences. 85(12). 1346–1349. 39 indexed citations

11.

Young, Linda R. De, Louis E. Burton, Jun Liu, et al.. (1996). RhNGF slow unfolding is not due to proline isomerization: Possibility of a cystine knot loop‐threading mechanism. Protein Science. 5(8). 1554–1566. 17 indexed citations

12.

Powell, Michael F., et al.. (1995). Vaccine design : the subunit and adjuvant approach. Plenum Press eBooks. 382 indexed citations

13.

Vogel, Frederick R. & Michael F. Powell. (1995). A Compendium of Vaccine Adjuvants and Excipients. Pharmaceutical biotechnology. 6. 141–228. 175 indexed citations

14.

Berman, Phillip W., Jeffrey L. Cleland, Donna J. Eastman, et al.. (1995). Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum.. Pharmaceutical Research. 12(10). 1439–1446. 38 indexed citations

15.

Newman, Mark J. & Michael F. Powell. (1995). Immunological and Formulation Design Considerations for Subunit Vaccines. Pharmaceutical biotechnology. 6. 1–42. 30 indexed citations

16.

Powell, Michael F., Tracy Murray Stewart, László Ötvös, et al.. (1993). Peptide Stability in Drug Development. II. Effect of Single Amino Acid Substitution and Glycosylation on Peptide Reactivity in Human Serum. Pharmaceutical Research. 10(9). 1268–1273. 158 indexed citations

17.

Sette, Alessandro, John Sidney, Carla Oseroff, et al.. (1993). HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.. The Journal of Immunology. 151(6). 3163–3170. 141 indexed citations

18.

Powell, Michael F. & Thomas C. Bruice. (1983). Effect of isotope scrambling and tunneling on the kinetic and product isotope effects for reduced nicotinamide adenine dinucleotide model hydride transfer reactions. Journal of the American Chemical Society. 105(24). 7139–7149. 88 indexed citations

19.

Kresge, A. J., et al.. (1977). Ortho ester hydrolysis. The complete reaction mechanism. Journal of the American Chemical Society. 99(14). 4827–4829. 13 indexed citations

20.

Powell, Michael F.. (1970). The eternal triangle.. BMJ. 2(5706). 416–418.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact